Suppr超能文献

阿福唑激活西格玛-1受体可减轻托利普/高迁移率族蛋白B1介导的CCN2自噬降解以及小鼠舒尼替尼诱导的心脏毒性中的中性粒细胞胞外诱捕网形成:肌醇需求酶1α/凋亡信号调节激酶1/应激活化蛋白激酶/激活蛋白-1信号通路的参与

Activation of Sig-1R by afobazole attenuates Tollip/HMGB1-mediaded CCN2 autophagic degradation and NETs formation in sunitinib-induced cardiotoxicity in mice: Involvement of IRE 1α/ASK1/JNK/ AP-1 trajectory.

作者信息

Shafik Marihan S, El-Tanbouly Dalia M, Bishr Abeer, Soubh Ayman A, Attia Amina S, Muhammad Radwa N

机构信息

Pharmacology and Toxicology Department, Faculty of Pharmacy, Ahram Canadian University, Egypt.

Pharmacology and Toxicology Department, Faculty of Pharmacy, Cairo University, Egypt.

出版信息

Toxicol Appl Pharmacol. 2025 Sep;502:117423. doi: 10.1016/j.taap.2025.117423. Epub 2025 May 29.

Abstract

Although the contribution of sigma1 receptor (Sig-1R) to afobazole's cardioprotection has been meticulously investigated, Sig-1R-mediated cardioprotective effect of afobazole against sunitinib cardiotoxicity has not been studied yet. Hence, we aimed at studying the potential modulatory impact of afobazole on Sig-1R to combat sunitinib-induced endoplasmic reticulum (ER) stress, maladaptive autophagy, and hyperactivation of neutrophils that ends up with neutrophil extracellular traps (NETs) formation. Pre-treatment with afobazole attenuated sunitinib-induced cardiotoxicity and enhanced cardiac function via significant reduction of TNNT2 and CK-MB, and restoration of nearly normal hemodynamic measurements. Afobazole-mediated Sig-1R activation mitigated the ER stress sensor, IRE1α activation and its downstream (ASK/JNK/AP-1) pathways along with caspase-3 and FK18. Subsequently, afobazole hindered NETs formation by prohibiting ER stress-induced activation of caspase-2 and pro-inflammatory cytokines; IL-1β and TNFα, as indicated by the significant reduction of NETs' specific components, namely, PAD4, NE, and MPO, along with the NETs' specific marker Cit H3. Afobazole also downregulated sunitinib-induced maladaptive autophagy, as reflected by reducing the expressions of autophagy-regulating proteins (ATG5 and ATG7) and microtubule-associated protein light chain 3 (LC3-II/I) ratio as well p62 upregulation. Furthermore, afobazole exhibited a cardioprotective effect by restoring nearly normal CCN2 level that was degraded by Tollip and HMGB1. The above-mentioned outcomes triggered by afobazole were clearly negated upon administration of the Sig-1R antagonist (BD1047), confirming that Sig-1R activation predominantly mediates the observed cardioprotective effects. Afobazole demonstrated efficacy in mitigating sunitinib-induced cardiotoxicity, as evidenced through the enhancements in hemodynamic stability, reduction of ER stress, amelioration of maladaptive autophagy, and inhibition of NETs formation.

摘要

尽管已经对σ1受体(Sig-1R)在阿伏苯唑心脏保护作用中的贡献进行了细致研究,但阿伏苯唑通过Sig-1R介导的抗舒尼替尼心脏毒性的心脏保护作用尚未得到研究。因此,我们旨在研究阿伏苯唑对Sig-1R的潜在调节作用,以对抗舒尼替尼诱导的内质网(ER)应激、适应性不良的自噬以及最终导致中性粒细胞胞外陷阱(NETs)形成的中性粒细胞过度活化。阿伏苯唑预处理通过显著降低肌钙蛋白T2(TNNT2)和肌酸激酶同工酶MB(CK-MB),以及恢复几乎正常的血流动力学测量值,减轻了舒尼替尼诱导的心脏毒性并增强了心脏功能。阿伏苯唑介导的Sig-1R激活减轻了内质网应激传感器肌醇需求酶1α(IRE1α)的激活及其下游(ASK/JNK/AP-1)途径以及半胱天冬酶-3和FK18。随后,阿伏苯唑通过抑制内质网应激诱导的半胱天冬酶-2和促炎细胞因子白细胞介素-1β(IL-1β)和肿瘤坏死因子α(TNFα)的激活来阻碍NETs形成,这表现为NETs的特定成分即肽基精氨酸脱亚氨酶4(PAD4)、中性粒细胞弹性蛋白酶(NE)和髓过氧化物酶(MPO)以及NETs的特定标志物瓜氨酸化组蛋白H3(Cit H3)的显著减少。阿伏苯唑还下调了舒尼替尼诱导的适应性不良的自噬,这表现为自噬调节蛋白(自噬相关蛋白5(ATG5)和自噬相关蛋白7(ATG7))的表达降低以及微管相关蛋白轻链3(LC3-II/I)比值降低以及p62上调。此外,阿伏苯唑通过恢复被Toll相互作用蛋白(Tollip)和高迁移率族蛋白B1(HMGB1)降解的结缔组织生长因子(CCN2)水平至几乎正常而发挥心脏保护作用。在给予Sig-1R拮抗剂(BD1047)后,阿伏苯唑引发的上述结果被明显抵消,这证实了Sig-1R激活主要介导了所观察到的心脏保护作用。阿伏苯唑在减轻舒尼替尼诱导的心脏毒性方面显示出疗效,这通过血流动力学稳定性增强、内质网应激减轻、适应性不良的自噬改善以及NETs形成抑制得到证明。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验